Physikron
2005
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$1.18M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of mass spectrometry technologies intended to improve the performance of tandem spectrometry. The company's technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during a LC/MS/MS acquisition, enabling researchers to research in an enhanced way.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Primary Office
- 4 rue Pierre Fontaine
- 91058 Évry Cedex
- France
+33 01 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Physikron’s full profile, request a free trial.
Physikron Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 14-Oct-2010 | $1.18M | 00.000 | Completed | Generating Revenue |
Physikron Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| CapDecisif Management | Venture Capital | Minority | 000 0000 | 000000 0 |
Physikron Executive Team (4)
Physikron Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Catherine Boule | CapDecisif Management | Board Member | 000 0000 | |
| Christian Policard | Self | Board Member | 000 0000 | |
| David Znaty | Self | Chief Executive Officer & Chairman | 000 0000 | |
| Olivier Dubuisson | CapDecisif Management | Board Member | 000 0000 | |
| Patrick Vayn | Physikron | Vice President & Board Member | 000 0000 |